Inhibitory potency against human acetylcholinesterase and enzymatic hydrolysis of Fluorogenic nerve agent mimics by human paraoxonase 1 and squid diisopropyl fluorophosphatase

被引:39
作者
Blum, Marc-Michael [1 ,2 ]
Timperley, Christopher M. [3 ]
Williams, Gareth R. [3 ]
Thiermann, Horst [1 ]
Worek, Franz [1 ]
机构
[1] Bundeswehr Inst Pharmacol & Toxicol, D-80937 Munich, Germany
[2] Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany
[3] Def Sci & Technol Lab, Salisbury SP4 0JQ, Wilts, England
关键词
D O I
10.1021/bi702222x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A wide range of toxic organophosphorus pesticides and nerve agents is effectively hydrolyzed by the structurally related phosphotriesterase enzymes paraoxonase (PON1) from human plasma and diisopropyl fluorophosphatase (DFPase) from the squid Loligo vulgaris. Both enzymes have potential use as medical countermeasures and decontaminants. Enhanced enzymatic activity, stereochemical preference, and substrate variety are still the focus of ongoing research. Derivatives of pesticides and nerve agents bearing a fluorogenic leaving group were introduced for high-throughput screening of mutant libraries recently. We report the inhibitory potency of fluorogenic organophosphorus compounds with three different leaving groups [3-chloro-7-oxy-4-methylcoumarin, 7-oxy-4-methylcoumarin, 7-oxy-4-(trifluoromethyl)coumarin] toward human acetylcholinesterase (AChE) and report kinetic data for the enzymatic hydrolysis of these compounds by PON1 and DFPase. This is the first report of the hydrolysis of a substrate bearing a P-O bond to the leaving group by DFPase (its activity was believed to be restricted to cleavage of P-F and P-CN bonds). The reactivity of the enzymes toward the substrates is explained on the basis of structural reasoning and computational docking studies. We demonstrate that fluorogenic organophosphorus compounds can serve as valuable models for enzyme screening but also show that differences and limitations exist and have to be taken into account. The importance of using protein from human sources to obtain toxicological data for potential in vivo use is highlighted.
引用
收藏
页码:5216 / 5224
页数:9
相关论文
共 52 条
[21]   Molar absorption coefficients for the reduced Ellman reagent: reassessment [J].
Eyer, P ;
Worek, F ;
Kiderlen, D ;
Sinko, G ;
Stuglin, A ;
Simeon-Rudolf, V ;
Reiner, E .
ANALYTICAL BIOCHEMISTRY, 2003, 312 (02) :224-227
[22]  
Eyer Peter, 2003, Toxicological Reviews, V22, P165, DOI 10.2165/00139709-200322030-00004
[23]   KINETICS FOR THE INHIBITION OF ACETYLCHOLINESTERASE FROM THE ELECTRIC-EEL BY SOME ORGANOPHOSPHATES AND CARBAMATES [J].
FORSBERG, A ;
PUU, G .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1984, 140 (01) :153-156
[24]  
GAN KN, 1991, DRUG METAB DISPOS, V19, P100
[25]   Mutagenesis of organophosphorus hydrolase to enhance hydrolysis of the nerve agent VX [J].
Gopal, S ;
Rastogi, V ;
Ashman, W ;
Mulbry, W .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 279 (02) :516-519
[26]   Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes [J].
Harel, M ;
Aharoni, A ;
Gaidukov, L ;
Brumshtein, B ;
Khersonsky, O ;
Meged, R ;
Dvir, H ;
Ravelli, RBG ;
McCarthy, A ;
Toker, L ;
Silman, I ;
Sussman, JL ;
Tawfik, DS .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2004, 11 (05) :412-419
[27]   RECORDING SPECTROPHOTOMETRIC METHOD FOR DETERMINATION OF DISSOCIATION AND PHOSPHORYLATION CONSTANTS FOR INHIBITION OF ACETYLCHOLINESTERASE BY ORGANOPHOSPHATES IN PRESENCE OF SUBSTRATE [J].
HART, GJ ;
OBRIEN, RD .
BIOCHEMISTRY, 1973, 12 (15) :2940-2945
[28]   High-yield expression, purification, and characterization of the recombinant diisopropylfluorophosphatase from Loligo vulgaris [J].
Hartleib, J ;
Rüterjans, H .
PROTEIN EXPRESSION AND PURIFICATION, 2001, 21 (01) :210-219
[29]   Insights into the reaction mechanism of the diisopropyl fluorophosphatase from Loligo vulgaris by means of kinetic studies, chemical modification and site-directed mutagenesis [J].
Hartleib, J ;
Rüterjans, H .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2001, 1546 (02) :312-324
[30]  
HOLMSTEDT B, 1959, PHARMACOL REV, V11, P567